Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Replimune Group Inc (NQ: REPL ) 12.44 +0.23 (+1.88%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Replimune Group Inc < Previous 1 2 Next > Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 08, 2024 From Replimune Group Inc Via GlobeNewswire Replimune to Present at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) October 30, 2024 From Replimune Group Inc Via GlobeNewswire REPL Stock Earnings: Replimune Group Beats EPS for Q1 2025 August 08, 2024 REPL stock results show that Replimune Group beat analyst estimates for earnings per share the first quarter of 2025. Via InvestorPlace Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session June 07, 2024 Via Benzinga Replimune Group: Q3 Earnings Insights February 08, 2024 Via Benzinga Barclays Maintains Overweight Rating for Replimune Group: Here's What You Need To Know December 06, 2023 Via Benzinga The Latest Analyst Ratings for Replimune Group August 01, 2023 Via Benzinga Analyst Ratings for Replimune Group June 07, 2023 Via Benzinga S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat June 06, 2024 Via Benzinga Topics Stocks Exposures US Equities Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 06, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session June 06, 2024 Via Benzinga Replimune Group Inc. (NASDAQ: REPL) Making Surprising Moves in Monday Session June 05, 2023 Via Investor Brand Network Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings June 06, 2024 Via Benzinga Exposures Fossil Fuels Why Is Mid-Cap Cancer-Focused Replimune Stock Trading Higher On Thursday? June 06, 2024 Replimune reported that the IGNYTE clinical trial of RP1 plus nivolumab in anti-PD1 failed melanoma showed a 33.6% response rate, with all responses lasting over six months. The treatment was... Via Benzinga J.M. SmuckerPosts Upbeat Earnings, Joins Toro Company, United Natural Foods, Semtech And Other Big Stocks Moving Higher On Thursday June 06, 2024 Via Benzinga REPL Stock Earnings: Replimune Group Misses EPS for Q4 2024 May 16, 2024 REPL stock results show that Replimune Group missed analyst estimates for earnings per share the fourth quarter of 2024. Via InvestorPlace Crude Oil Moves Lower; AutoZone Profit Tops Views December 05, 2023 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher on Tuesday. The Dow traded down 0.18% to 36,138.19 while the NASDAQ rose 0.19% to 14,212.19. The S&P 500... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session December 05, 2023 Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session December 05, 2023 Via Benzinga Dow Falls 100 Points; ISM Services PMI Increases In November December 05, 2023 U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Tuesday. The Dow traded down 0.28% to 36,103.52 while the NASDAQ rose 0.32% to 14,230.64. The S&P... Via Benzinga Topics Stocks Exposures US Equities Why Is Replimune (REPL) Stock Down 48% Today? December 05, 2023 Replimune stock is dropping on Tuesday as investors in REPL shares react to a clinical trial missing both of its primary endpoints. Via InvestorPlace US Stocks Down; JM Smucker Posts Upbeat Earnings December 05, 2023 U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.23% to 36,120.88 while the NASDAQ fell... Via Benzinga Topics Stocks Exposures US Equities What's Going On With Cancer-Focused Replimune Stock Today? December 05, 2023 Replimune Group Inc (NASDAQ: REPL) announced results from the primary analysis of the CERPASS trial evaluating RP1 in combination with cemiplimab for locally advanced or metastatic cutaneous Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session December 05, 2023 Via Benzinga 8 Health Care Stocks Whale Activity In Today's Session November 07, 2023 Via Benzinga Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma July 31, 2023 From Incyte Via Business Wire Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review June 09, 2023 The Nasdaq held near 52-week highs while small caps ramped up. Via Investor's Business Daily 12 Health Care Stocks Moving In Monday's Intraday Session June 05, 2023 Via Benzinga Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 05, 2023 Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. Via Benzinga ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes June 05, 2023 ImmunoGen and Day One gained Monday on their updates at a cancer treatment conference. Via Investor's Business Daily < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
